<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02296593</url>
  </required_header>
  <id_info>
    <org_study_id>A14-D36-VOL.22</org_study_id>
    <nct_id>NCT02296593</nct_id>
  </id_info>
  <brief_title>Continuous MONItoring of Blood LActate and Glucose Levels Using a New Central Veinous Microdialysis Catheter Device</brief_title>
  <acronym>MONILAG</acronym>
  <official_title>Monitorage Continu du Lactate et de la glycémie Par Microdialyse : Une étude de Validation en Chirurgie Cardiaque.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Caen</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Caen</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Continuous lactate and glucose blood levels
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      MAQUET Group offers a new device that gives real time blood lactate and glucose levels. It is
      a new central veinous catheter with a microdialysis system. It is planted in the superior
      vena cava. It has not yet been used and validated with a clinical purpose, and particularly
      in cardiac surgery.

      For now, reference method for determining blood lactate and glucose levels is co oxymetry.

      This new simple device could provide great fluency for determining blood lactate and glucose
      levels. It could allow medical teams gain time for diagnosis and treatment of both
      hyperlactatemia and hyperglycemia.

      The primary outcome of this study was to compare blood lactate and glucose absolute measures
      provided with the MAQUET new device (Maquet Critical Care AB, Solna, Sweden) and with co
      oxymetry.

      The secondary outcome of this study was to compare variations of these absolutes measures.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>November 2014</start_date>
  <completion_date type="Actual">November 2016</completion_date>
  <primary_completion_date type="Actual">May 2016</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>comparison of absolute blood lactate and glucose levels with the reference method (co oxymetry) and a new method using a device providing real time measures of lactate and glycemia with a central veinous catheter microdialysis system.</measure>
    <time_frame>1 day</time_frame>
    <description>Central veinous catheter, EIRUS (Maquet Critical Care AB, Solna, Sweden)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>comparison of variations of blood lactate and glycemia levels with the reference method (co oxymetry) and a new method using a device providing real time measures of lactate and glycemia. (EIRUS) with a central veinous catheter microdialysis system.</measure>
    <time_frame>1 day</time_frame>
    <description>Central veinous catheter, EIRUS (Maquet Critical Care AB, Solna, Sweden)</description>
  </secondary_outcome>
  <enrollment type="Actual">20</enrollment>
  <condition>Other Functional Disturbances Following Cardiac Surgery</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>comparison of blood lactate and glucose levels</intervention_name>
    <description>comparison of blood lactate and glucose levels with the reference method (co oxymetry) and a new central veinous catheter microdialysis system provided by MAQUET. (Critical Care AB, Solna, Sweden.)</description>
    <other_name>EIRUS</other_name>
    <other_name>continuous lactate monitoring</other_name>
    <other_name>continuous glycemia monitoring</other_name>
    <other_name>central veinous catheter</other_name>
    <other_name>microdialysis system</other_name>
    <other_name>MAQUET</other_name>
  </intervention>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Blood samples for determination of lactate and glucose blood levels
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Consecutive patients of cardiac surgery. (planned or for emergencies)
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Men or women more than 18 years old.

          -  Cardiac surgery.

          -  Central veinous catheter in superior vena cava.

        Exclusion Criteria:

          -  Men or women less than 18 years old.

          -  Pregnant women.

          -  Central veinous catheter not in superior vena cava.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>CHU de Caen</name>
      <address>
        <city>Caen</city>
        <state>Basse Normandie</state>
        <zip>14000</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>March 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 18, 2014</study_first_submitted>
  <study_first_submitted_qc>November 19, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 20, 2014</study_first_posted>
  <last_update_submitted>March 6, 2017</last_update_submitted>
  <last_update_submitted_qc>March 6, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">March 7, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>lactate</keyword>
  <keyword>continuous lactate monitoring</keyword>
  <keyword>continuous blood glucose monitoring</keyword>
  <keyword>EIRUS</keyword>
  <keyword>blood glucose</keyword>
  <keyword>cardiac surgery</keyword>
  <keyword>central veinous catheter</keyword>
  <keyword>microdialysis</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pathologic Processes</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

